Takeaki Suzuki

Statistics

Publications

Citations

187

H-Index

Active since

2005

Affiliations

Japan Science and Technology Agency(Current)

Tokyo Institute of Technology

Fujifilm (Japan)

Sidney Kimmel Comprehensive Cancer Center

Johns Hopkins University

Takeaki Suzuki is an author at Japan Science and Technology Agency specializing in ring system diversification, heterocycle synthesis, and organic synthesis.

Publications per year

2005–2024

Publications

Tandem Ring Expansion of Alkenyl Benzocyclobutenol Derivatives into Substituted Naphthols

Toshiyuki Hamura, Takeaki Suzuki, Takashi Matsumoto et al. · Angewandte Chemie International Edition · 2006 · 43 citations

Natural Sciences, Chemistry, Drug Discovery +13

Ring Selectivity: Successive Ring Expansion of Two Benzocyclobutenes for Divergent Access to Angular and Linear Benzanthraquinones

Takeaki Suzuki, Toshiyuki Hamura, Keisuke Suzuki · Angewandte Chemie International Edition · 2008 · 41 citations · Full text

Natural Sciences, Chemistry, Medicinal Chemistry +14

Phase I Study of P-cadherin–targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors

Vivek Subbiah, William D. Erwin, Osama Mawlawi et al. · Clinical Cancer Research · 2020 · 30 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemia

Mark J. Levis, Alexander E. Perl, Gary J. Schiller et al. · Blood Advances · 2024 · 21 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Phase 1 first-in-human study of irreversible FLT3 inhibitor FF-10101-01 in relapsed or refractory acute myeloid leukemia.

Mark J. Levis, Catherine C. Smith, Alexander E. Perl et al. · Journal of Clinical Oncology · 2021 · 15 citations

Medicine, Oncology, Pharmacology +15

1–5 of 8